Japan
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.
Its Bisu Body Coach provides personalised health advice through urine and saliva testing.
This collaboration will work with an unnamed pharma company in Japan to know how its drugs behave compared to rival products.
The app provides personalised treatment guidance to users based on their BP record, habit logs and behavioural changes.
The diagnostic software runs on Lunit's AI technology to spot major abnormal findings.
The three-year partnership seeks to derive insights that can be applied to Otsuka's products and other offerings.
They are also seeking ways to improve high blood pressure management.
The Singaporean firm has also partnered with Japan's Toho Holdings to develop and market its device.
The conpany uses its own spectroscopic technology to detect, analyse, and quantify molecular information.
The companies will develop a solution based on a new technique of flow cytometry that enables fast and accurate cell analysis using AI.